- 全部删除
- 您的购物车当前为空
6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).16-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2
6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).16-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | 待估 | 35日内发货 | |
250 mg | 待估 | 35日内发货 | |
500 mg | 待估 | 35日内发货 |
6-Hydroxypyridin-3-ylboronic Acid 相关产品
产品描述 | 6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).16-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2 |
分子量 | 138.92 |
分子式 | C5H6BNO3 |
CAS No. | 903899-13-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO:PBS (pH 7.2) (1:5): 0.16 mg/mL (1.15 mM), Sonication is recommended. DMSO: 30 mg/mL (215.95 mM), Sonication is recommended. Ethanol: 1 mg/mL (7.2 mM), Sonication is recommended. DMF: 30 mg/mL (215.95 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO/DMF
DMSO/DMF
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容